Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,257.4
16.8 (0.52%)

 

  • STI Straits Times Index
    3,257.4
    16.8 (0.52%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,609.7
    -
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,947.7
    21.1 (0.08%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,897.2
    -12.7 (-0.44%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,359.9
    28.0 (0.12%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,145.0
    -3.7 (-0.06%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,127.5
    3.4 (0.16%)
    Index delayed 20 minutes
  • XAO XAO
    6,843.0
    -34.0 (-0.49%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,309.3M
  • Value: 1,211.9M
  • Rise: 207
  • Fall: 116
  • Unch: 505

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Golden Agri-Res0.260+0.030
Rex Intl0.189-0.010
Tritech0.027+0.007
Jiutian Chemical0.017+0.002
United Engineers2.700+0.050
Spackman0.016+0.001
MarcoPolo Marine0.022-
Alpha Energy0.034-0.002
GSS Energy0.103-
YZJ Shipbldg SGD0.980-

World Indices

World Indices
Name Last Change
Nasdaq 8,464.3 -11.0
HSI 26,947.7 +21.1
HSCEI 10,640.8 +27.1
Jakarta 6,145.0 -3.7
Nikkei 225 23,359.9 +28.1
SSE Comp 2,897.2 -12.7
Shanghai A 3,035.4 -13.3
Shanghai B 258.1 -1.8
PSE Comp 0.0
KOSPI 2,127.5 +3.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

BIONANO GENOMICS INC BIONANO GENOMICS
Updated on 11 Nov 2019 (End of trading day)
Last (USD): 0.855 Change: -0.026 High: 0.894 Remarks: -
Change (%): -2.91 Low: 0.820
Open 0.881 Yesterday's Close 0.8801
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 2,125,472 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.88453 Trailing EPS (USD) e -1.04862 NAV (USD) b -
PE a - Trailing PE f - Price / NAV b -
Dividend (USD) d - Cash In Hand (USD) g 0.3933 Issued & Paid-up Shares c 26,490,000
Dividend Yield (%) d - Price / Cash In Hand g 2.173 Treasury Shares h -
Beta - 75 Daysi -2.471 R-Squared - 75 Days(%)i 0.52 Market Cap (M) 17.868
Beta - 500 Daysi -0.587 R-Squared - 500 Days (%)i 0.09 Enterprise Value (M) 29.373
Piotroski F Score 2 Exchange Code BNGO Par Value ( $ ) n.a.
52 Weeks Volatility (%) 158.99 Free Float (%) 17.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 26 Jul 2018.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference BIONANO GENOMICS INC NASDAQ 17.868 - - - -
Industry Biotechnology NASDAQ 2,350.778 138.218 139.317 5.6878 0.742
Local Peer AMGEN INC NASDAQ 131,136.409 15.623 16.256 12.0012 2.535
Local Peer GILEAD SCIENCES INC NASDAQ 81,779.296 14.992 30.367 3.9691 3.574
Local Peer CELGENE CORP NASDAQ 77,982.503 19.274 13.262 6.4518 -
Local Peer BIOGEN INC NASDAQ 53,075.210 11.979 9.837 3.7922 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 51,918.585 24.766 24.218 9.8829 -
Local Peer ILLUMINA INC NASDAQ 43,365.000 52.500 44.568 9.7691 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 37,800.557 15.464 17.629 3.5985 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,122.932 310.862 16.407 2.3269 -
Local Peer SEATTLE GENETICS INC NASDAQ 18,561.104 - - 10.4299 -
Local Peer INCYTE CORPORATION NASDAQ 18,278.589 166.939 45.136 7.5453 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 13,531.151 - - 4.4012 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 12,244.788 - 37.854 4.2505 -
Other Local Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), REPLIGEN CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), FIBROGEN INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ACCELERON PHARMA (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), INSMED INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), EPIZYME INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), RADIUS HEALTH INC (NASDAQ), ALECTOR INC (NASDAQ), VERACYTE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), INTREXON CORP (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ARVINAS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), TRANSLATE BIO INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), RETROPHIN INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), AGENUS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), SYNTHORX INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MORPHIC HOLDING INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), AVROBIO INC (NASDAQ), DERMIRA INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), MACROGENICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MERUS B V (NASDAQ), PROTHENA CORP PLC (NASDAQ), BELLUS HEALTH INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), COMPUGEN (NASDAQ), PERSONALIS INC (NASDAQ), MEDICINOVA INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ANAPTYSBIO INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), GLYCOMIMETICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CABALETTA BIO INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), CHIASMA INC (NASDAQ), KAMADA (NASDAQ), XOMA CORP (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ATHERSYS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), IMV INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SESEN BIO INC (NASDAQ), NANTKWEST INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NOVAVAX INC (NASDAQ), CHIMERIX INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ADURO BIOTECH INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), COHBAR INC (NASDAQ), VERASTEM INC (NASDAQ), OTONOMY INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), VACCINEX INC (NASDAQ), SYNLOGIC INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), INFLARX N V (NASDAQ), TREVENA INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), VERMILLION INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), EQUILLIUM INC (NASDAQ), ORGENESIS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), INMUNE BIO INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CURIS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), ZAFGEN INC (NASDAQ), BIOCARDIA INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SOLIGENIX INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), SENESTECH INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), SOPHIRIS BIO INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), TOCAGEN INC (NASDAQ), BIOCEPT INC (NASDAQ), ATYR PHARMA INC (NASDAQ), PRECIPIO INC (NASDAQ), TROVAGENE INC (NASDAQ), VAXART INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 20 ORD SHS (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), OCUGEN INC (NASDAQ), ADVAXIS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), SPHERIX INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), OPGEN INC (NASDAQ)
Global Peer CSL ASX 120,960.361 45.085 45.085 16.1644 0.996
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,782.616 75.261 22.185 5.0100 0.797
Global Peer SINO BIOPHARM HKEx 140,589.540 13.121 13.541 4.1303 0.655
Global Peer WUXI BIO HKEx 109,791.155 146.993 114.916 10.8913 -
Global Peer BEIGENE HKEx 90,291.905 - - 7.4378 -
Global Peer GENSCRIPT BIO HKEx 34,959.072 210.243 - 9.8586 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer 3SBIO HKEx 33,527.604 22.163 26.976 3.3045 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,773.500 44.234 645.000 2.6797 -
Other Global Peers HAOHAI BIOTEC (HKEx), CKLIFE SCIENCES (HKEx), FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), VIVA BIOTECH (HKEx), ASCENTAGE-B (HKEx), AVITA MEDICAL LTD (ASX), MESOBLAST LTD (ASX), ASCLETIS-B (HKEx), MYOVANT SCIENCES LTD (NYSE), ESSEX BIO-TECH (HKEx), KADMON HLDGS INC (NYSE), ARCUS BIOSCIENCES INC (NYSE), LEE'S PHARM (HKEx), STARPHARMA HOLDINGS LIMITED (ASX), TELIX PHARMACEUTIC (ASX), NEXT SCIENCE LTD (ASX), PFENEX INC (NYSE American), DPHARMA (Bursa), NEUREN PHARMACEUTICALS LTD (ASX), 22ND CENTURY GROUP INC (NYSE American), BBI LIFE SCI (HKEx), UNI-BIO GROUP (HKEx), RESAPP HEALTH LIMITED (ASX), ENZO BIOCHEM INC (NYSE), NANOVIRICIDES INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), PHYLOGICA LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), IMUGENE LIMITED (ASX), ONCOSIL MEDICAL LIMITED (ASX), CEL-SCI CORP (NYSE American), ORTHOCELL LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), PORT (SET), ARMATA PHARMACEUTICALS INC (NYSE American), BIONOMICS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), BIOTRON (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), MEMPHASYS LTD (ASX), RHINOMED LIMITED (ASX), BIOSINO BIO-TEC (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), ORAGENICS INC (NYSE American), EXTRAWELL PHAR (HKEx), ACTINIUM PHARMACEUTICALS INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), ISORAY INC (NYSE American), PROTEOMICS INTL LABORATORIES LTD (ASX), IMMURON LIMITED (ASX), PATRYS LIMITED (ASX), IBIO INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), Suntar Eco-City^ (SGX), REGENEUS LTD (ASX), CELLMID LIMITED (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), GENETIC TECHNOLOGIES (ASX), HOLISTA COLLTECH LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), CCP TECHNOLOGIES LTD (ASX), MEGASUN (Bursa), AUSTRALIAN PRIMARY HEMP LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), HAO WEN HLDGS (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), BIOXYNE LIMITED (ASX), MEDIBIO LIMITED (ASX), MGRC (Bursa), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), IMMUTEP LTD (ASX), TBG DIAGNOSTICS LTD (ASX), AIM IMMUNOTECH INC (NYSE American), QT Vascular (SGX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), BPH ENERGY LIMITED (ASX), SINOMAB BIO-B (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.044
+5.49 %
10 Days -+0.110
+14.70 %
20 Days -+0.303
+55.08 %
Medium Term Return 3 Months --1.115
-56.60 %
6 Months --2.365
-73.46 %
1 Year --6.096
-87.71 %
Annualised Return Annualised --
-87.71 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.500 - 8.000 Change From 1 Year Low +0.354 % Change From 1 Year Low (%) +70.90
Change From 1 Year High -7.146 % Change From 1 Year High (%) -89.32
2 Years Range 0.500 - 10.000 Change From 2 Years Low +0.354 % Change From 2 Years Low (%) +70.90
Change From 2 Years High -9.146 % Change From 2 Years High (%) -91.45
5 Years Range 0.500 - 10.000 Change From 5 Years Low +0.354 % Change From 5 Years Low (%) +70.90
Change From 5 Years High -9.146 % Change From 5 Years High (%) -91.45
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
11 Nov 2019 0.881 0.894 0.820 0.855 2,125,472 -
08 Nov 2019 0.900 1.020 0.850 0.880 6,078,339 -
07 Nov 2019 1.380 1.500 0.971 1.020 58,238,640 -
06 Nov 2019 0.800 0.905 0.770 0.899 3,485,618 -
05 Nov 2019 0.819 0.827 0.790 0.810 1,302,897 -
04 Nov 2019 0.880 0.888 0.800 0.810 1,918,910 -
01 Nov 2019 0.801 0.870 0.770 0.847 1,852,496 -
31 Oct 2019 0.839 0.839 0.750 0.790 2,905,262 -
30 Oct 2019 0.835 0.960 0.823 0.850 8,853,787 -
29 Oct 2019 0.790 0.799 0.710 0.745 3,671,904 -
28 Oct 2019 0.909 0.915 0.800 0.815 4,008,384 -
25 Oct 2019 0.980 1.000 0.870 0.892 6,454,079 -
24 Oct 2019 1.140 1.150 1.000 1.010 6,663,906 -
23 Oct 2019 1.150 1.260 1.050 1.100 7,520,070 -
22 Oct 2019 1.080 1.170 0.985 1.160 9,350,592 -
21 Oct 2019 0.910 1.270 0.822 1.080 37,431,330 -
18 Oct 2019 1.710 3.980 1.710 1.900 68,036,980 -
17 Oct 2019 2.020 2.320 1.290 1.380 6,203,517 -
16 Oct 2019 1.120 4.700 1.050 2.850 34,621,820 -
15 Oct 2019 0.505 0.607 0.500 0.551 104,892 -
14 Oct 2019 0.610 0.610 0.500 0.521 150,609 -
11 Oct 2019 0.599 0.599 0.570 0.584 11,971 -
Summary
Current 2 Weeks
(29 Oct 2019 to 11 Nov 2019)
0.790 1.500 0.710 0.855 90,433,325 -
Previous 2 Weeks
(15 Oct 2019 to 28 Oct 2019)
0.505 1.500 0.500 0.815 180,395,570 -
4 Weeks from
(17 Sep 2019 to 14 Oct 2019)
1.184 1.500 0.710 0.521 1,635,894 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.